Table 3.
Control | Hyaluronidase | |||
---|---|---|---|---|
Baseline N = 5 |
Adenosine | Baseline N = 6 |
Adenosine | |
Heart rate (bpm) | 384 ± 17 | 327 ± 21† | 425 ± 24 | 334 ± 19† |
EDV (µl) | 316 ± 33 | 348 ± 30 | 232 ± 21 | 273 ± 38 |
ESV (µl) | 83 ± 18 | 55 ± 8 | 64 ± 6 | 74 ± 13 |
SV (µl) | 233 ± 42 | 294 ± 27 | 168 ± 17 | 199 ± 44 |
EF (%) | 72 ± 5 | 84 ± 2 | 72 ± 2 | 71 ± 6 |
Data are expressed as mean ± SEM
EDV end-diastolic volume, SV stroke volume, EF ejection fraction
* p < 0.05 vs. control group, † p < 0.05 adenosine effect. No significant differences were found for the intervention group hyaluronidase compared to the control group